|
BE791889A
(fr)
|
1971-11-26 |
1973-05-24 |
Pharmacia Ab |
Nouveaux derives de la pyridine
|
|
US4298595A
(en)
|
1978-12-20 |
1981-11-03 |
Dynapol |
Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
|
|
US4960765A
(en)
|
1980-03-20 |
1990-10-02 |
Farmaceutisk Laboratorium Ferring A/S |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
|
|
JPS57500432A
(enExample)
|
1980-03-20 |
1982-03-11 |
|
|
|
EP0039306B1
(de)
|
1980-03-28 |
1984-01-11 |
Ciba-Geigy Ag |
Neue Azofarbstoffe, Verfahren zu deren Herstellung und deren Verwendung
|
|
US4412922A
(en)
|
1980-07-02 |
1983-11-01 |
Abcor, Inc. |
Positive-charged ultrafiltration membrane for the separation of cathodic/electrodeposition-paint compositions
|
|
US4412992A
(en)
|
1980-07-21 |
1983-11-01 |
Biorex Laboratories Limited |
2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
|
|
ZA825384B
(en)
|
1981-07-31 |
1983-05-25 |
Tillott J B Ltd |
Orally administrable pharmaceutical compositions
|
|
US4562024A
(en)
|
1982-07-06 |
1985-12-31 |
Sterling Drug Inc. |
Process for preparing granulate containing poorly compressible medicinally active matter
|
|
SE8405924L
(sv)
|
1984-11-23 |
1986-05-24 |
Pharmacia Ab |
Nya azoforeningar
|
|
US4781925A
(en)
*
|
1986-03-06 |
1988-11-01 |
American Home Products Corporation |
Calcium supplement compressed tablets
|
|
US5374430A
(en)
|
1986-09-18 |
1994-12-20 |
London School Of Pharmacy |
Pharmaceutical formulation
|
|
EP0439453B1
(en)
|
1987-10-12 |
1994-01-19 |
Exomed Australia Pty. Ltd. (ACN 051 976 446) |
Improved method for treatment of gastrointestinal disorders
|
|
US5064637A
(en)
|
1989-05-30 |
1991-11-12 |
Board Of Regents, The University Of Texas System |
Substituted sulfonamide derivatives which inhibit allergic reactions
|
|
US5095073A
(en)
|
1990-03-02 |
1992-03-10 |
Exxon Research And Engineering Company |
Water soluble rigid rod sulfonated aromatic polyamide
|
|
SE9003296L
(sv)
|
1990-10-16 |
1992-04-17 |
Kabi Pharmacia Ab |
Foerfarande foer att formulera laekemedel
|
|
US5519014A
(en)
|
1990-10-22 |
1996-05-21 |
Borody; Thomas J. |
Treatment of non-inflammatory and non-infectious bowel disorders
|
|
EP0560092B1
(de)
|
1992-03-11 |
1997-12-03 |
ASTA Medica Aktiengesellschaft |
Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
|
|
US5498608A
(en)
|
1994-01-07 |
1996-03-12 |
Salix Pharmaceuticals |
Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
|
|
JPH08169847A
(ja)
|
1994-12-16 |
1996-07-02 |
Morishita Roussel Kk |
固形製剤
|
|
US5905073A
(en)
|
1995-01-06 |
1999-05-18 |
Salix Pharmaceuticals, Inc. |
Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
|
|
US6562629B1
(en)
|
1999-08-11 |
2003-05-13 |
Cedars-Sinai Medical Center |
Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
|
|
US6231888B1
(en)
|
1996-01-18 |
2001-05-15 |
Perio Products Ltd. |
Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
|
|
SE9700934D0
(sv)
|
1997-03-14 |
1997-03-14 |
Astra Ab |
New formulation
|
|
ATE389417T1
(de)
|
1997-04-01 |
2008-04-15 |
Borody Thomas J |
Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen
|
|
US6551632B2
(en)
|
1997-04-01 |
2003-04-22 |
Thomas Julius Borody |
Methods and compositions for treating inflammatory bowel disease
|
|
AUPO665397A0
(en)
|
1997-05-07 |
1997-05-29 |
Borody, Thomas Julius |
Novel therapy for constipation
|
|
US6144381A
(en)
|
1997-05-14 |
2000-11-07 |
International Business Machines Corporation |
Systems, methods and computer program products for compass navigation of avatars in three dimensional worlds
|
|
DE19732903A1
(de)
|
1997-07-30 |
1999-02-04 |
Falk Pharma Gmbh |
Pellet-Formulierung zur Behandlung des Intestinaltraktes
|
|
ES2292682T3
(es)
|
1998-05-06 |
2008-03-16 |
Genentech, Inc. |
Purificacion de anticuerpos mediante cromatografia de intercambio ionico.
|
|
US5927500A
(en)
|
1998-06-09 |
1999-07-27 |
Milliken & Company |
Pharmaceutical containment package
|
|
AUPP437698A0
(en)
|
1998-06-30 |
1998-07-23 |
Baumgart, Karl |
Methods for treatment of coronary, carotid and other vascular disease
|
|
BR9912145A
(pt)
|
1998-07-20 |
2001-09-25 |
Smithkline Beecham Corp |
Formulações bioaperfeiçoadas contendo eprosartan em forma de dosagem sólida oral
|
|
KR20000011247A
(ko)
|
1998-07-23 |
2000-02-25 |
김윤 |
다당류를이용한대장선택성약물전달조성물및약학제제
|
|
US6326364B1
(en)
|
1999-02-08 |
2001-12-04 |
Cedars-Sinai Medical Center |
Use of 5-aminosalicylates as antimicrobial agents
|
|
US20030138399A1
(en)
|
1999-05-14 |
2003-07-24 |
Anton Peter A. |
Anti-inflammatory therapy for inflammatory mediated infection
|
|
AU8531101A
(en)
|
2000-08-29 |
2002-03-13 |
Nobex Corp |
Immunoregulatory compounds and derivatives and methods of treating diseases therewith
|
|
ATE460394T1
(de)
|
2000-08-29 |
2010-03-15 |
Biocon Ltd |
5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
|
|
US6562871B1
(en)
|
2000-11-06 |
2003-05-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Dry granulation of pharmaceutical formulation comprising mexiletine
|
|
CA2359812C
(en)
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
|
WO2003011117A2
(en)
|
2001-07-31 |
2003-02-13 |
The General Hospital Corporation |
Methods and compositions for treating and preventing distal bowel lesions
|
|
US6407128B1
(en)
|
2001-12-03 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Method for increasing the bioavailability of metaxalone
|
|
AU2003226748A1
(en)
|
2002-03-28 |
2003-10-13 |
Synthon B.V. |
Compositions of venlafaxine base
|
|
US8216609B2
(en)
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
US20060177444A1
(en)
|
2003-03-20 |
2006-08-10 |
Tatsuo Horizoe |
Concomitant drug as therapeutic agent for inflammatory bowel disease
|
|
US7737133B2
(en)
|
2003-09-03 |
2010-06-15 |
Agi Therapeutics Ltd. |
Formulations and methods of treating inflammatory bowel disease
|
|
US7825106B2
(en)
|
2003-09-03 |
2010-11-02 |
Agi Therapeutics Ltd. |
Modified release formulations and methods of treating inflammatory bowel disease
|
|
WO2005030173A1
(en)
|
2003-09-25 |
2005-04-07 |
Ranbaxy Laboratories Limited |
Colon-specific drug delivery using interpolymer complexations
|
|
EP2361620B1
(en)
|
2004-02-06 |
2016-04-06 |
PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST |
Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
|
|
NZ603744A
(en)
|
2005-08-24 |
2014-06-27 |
Salix Pharmaceuticals Inc |
Balsalazide formulations and manufacture and use thereof
|
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
WO2008033125A1
(en)
|
2006-09-13 |
2008-03-20 |
The Procter & Gamble Company |
Methods of treatment for ulcerative colitis using aminosalicylate
|